Early and locally advanced breast cancer: costing report

A costing report and costing template have been produced by NICE to provide an implementation tool to estimate the financial impact to the NHS of implementing the clinical guidelines CG80 Early and locally advanced breast cancer and CG81 Advanced breast cancer.

The costing report focuses on the financial impact of the recommendations that require most change in resources to implement in England. The report has been prepared in consultation with the two guideline development groups, and other clinicians working in this area and has been approved for publication by the Institute. It should be noted that the cost and activity assessments in the report are estimates based on a number of assumptions. These assessments provide an indication of the likely impact of the principal recommendations and are not absolute figures.

As part of this work, a costing template has been developed to provide health communities with the ability to assess the likely local impact of the principal recommendations in the clinical guidelines based on local population. Other assumptions can be altered to better reflect local circumstances.

To support implementation slide sets have also been produced.

The Institute would welcome feedback from users to inform the development of future templates. Please email your comments to costing@nice.org.uk